Resistance to both complement activation and phagocytosis in type 3 pneumococci is mediated by the binding of complement regulatory protein factor H

Infection and Immunity

Volumn 67, Issue 9, 1999, Pages 4517-4524

  Neeleman, Chris ^a,b   Geelen, Sibyl P M ^a,c   Aerts, Piet C ^a,c   Daha, Mohammed R ^d   Mollnes, Tom E ^e   Roord, John J ^c   Posthuma, George ^f   Van Dijk, Hans ^a   Fleer, André ^a,c  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^e NORDLAND HOSPITAL   (Norway)

^f UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; REGULATOR PROTEIN; REGULATOR PROTEIN FACTOR H; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BACTERIUM IDENTIFICATION; COMPLEMENT ACTIVATION; CONTROLLED STUDY; IMMUNOELECTRON MICROSCOPY; IMMUNOGOLD STAINING; MALE; MOUSE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; REGULATOR GENE; STRAIN DIFFERENCE; STREPTOCOCCUS PNEUMONIAE;

EID: 0032797582     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.67.9.4517-4524.1999     Document Type: Article

References (47)

1. Alonso De Velasco, E., A. F. Verheul, J. Verhoef, and H. Snippe. 1995. Streptococcus pneumoniae: virulence factors, pathogenesis, and vaccines. Microbiol. Rev. 59:591-603.
2. Alonso De Velasco, E., B. A. Dekker, A. F. Verbeul, R. G. Feldman, J. Verhoef, and H. Snippe. 1995. Antipolysaccharide immunoglobulin isotype levels and opsonic activity of antisera: relationships with protection against Streptococcus pneumoniae infection in mice. J. Infect. Dis. 172:562-565.
3. Angel, C. S., M. Ruzek, and M. K. Hosteller. 1994. Degradation of C3 by Streptococcus pneumoniae. J. Infect. Dis. 170:600-608.
4. Austrian, R. 1982. Some observations on the pneumococcus and on the current status of pneumococcal disease and its prevention, p. 191-207. In P. G. Quie and E. H. Kass (ed.), The pneumococcus and the pneumococcal vaccine. University of Chicago Press, Chicago, Ill.
5. Berry, A. M., J. Yother, D. E. Briles, D. Hansman, and J. C. Paton. 1989. Reduced virulence of a defined pneumolysin negative mutant of Streptococcus pneumoniae. Infect. Immun. 57:2037-2042.
6. Berry, A. M., and J. C. Paton. 1996. Sequence heterogenity of PsaA, a putative adhesin essential for virulence of Streptococcus pneumoniae. Infect. Immun. 64:5255-5262.
7. Boyle, M. D. P., A. P. Gee, M. Okada, and T. Borsos. 1980. Differences in cell bound C8 sites on chicken erythrocytes measured by their reactivity with guinea pig and human C9. J. Immunol. 125:2818-2822.
8. Briles, D. E., J. Yother, and L. S. McDaniel. 1988 Role of pneumococcal surface protein A in the virulence of Streptococcus pneumoniae. Rev. Infect. Dis. 10:8372-5374.
9. Briles, D. E., J. D. King, M. A. Gray, L. S. McDaniel, E. Swiatlo, and K. A. Benton. 1996. PspA, a protection-eliciting pneumococcal protein: immunogenicity of isolated native PspA in mice. Vaccine 14:858-867.
10. Brown, E., K. Joiner, T. Gaither, C. Hammer, and M. M. Frank. 1983. The interaction of C3b bound to pneumococci with factor H, factor I and properdin factor B of the human complement system. J. Immunol. 131:409-415.
11. Brown, E. J., S. W. Hosea, C. H. Hammer, C. G. Burch, and M. M. Frank. 1982. A quantitative analysis of the interactions of antipneumococcal antibody and complement in experimental pneumococcal bacteremia. J. Clin. Investig. 69:85-98.
12. Brown, E. J., S. W. Hosea, and M. M. Frank. 1983. The role of antibody and complement in the reticuloendothelial clearance of pneumococci from the blood stream. Rev. Infect. Dis. 5:S797-S805.
13. Burman, L. A., R. Norrby, and B. Trollfors. 1985. Invasive pneumococcal infections: incidence, predisposing factors, and prognosis. Rev. Infect. Dis. 7:133-142.
14. Fine, D. P. 1975. Pneumococcal type-associated variability in alternate complement pathway activation. Infect. Immun. 12:772-778.
15. Finland, M., and M. W. Barnes. 1977. Changes in the occurrence of capsular serotypes of Streptococcus pneumoniae at Boston City Hospital during selected years between 1935 and 1974. J. Clin. Microbiol. 5:154-166.
16. Fischetti, V. A. 1989. Streptococcal M protein: molecular design and biological behavior. Clin. Microbiol. Rev. 2:285-314.
17. Geelen, S. P. M., P. C. Aerts, J. Verhoef, A. Fleer, and H. van Dijk. 1992. Functional microassay of complement activation by pneumococci. J. Microbiol. Methods 14:257-265.
18. Hammerschmidt, S., S. R. Talay, P. Brandtzaeg, and G. S. Ghhatwal. 1997. SpsA, a novel pneumococcal surface protein with specific binding to secretory immunoglobulin A and secretory component. Mol. Microbiol. 25:1113-1124.
19. Horstmann, R., H. J. Sievertsen, J. Knobloch, and V. A. Fischetti. 1988. Antiphagocytic activity of streptococcal M-protein: selective binding of complement control protein factor H. Proc. Natl. Acad. Sci. USA 85:1657-1661.
20. Hosea, S. W., E. J. Brown, and M. M. Frank. 1980. The critical role of complement in experimental pneumococcal sepsis. J. Infect. Dis. 142:903-909.
21. Hostetter, M. K. 1986. Serotypic variations among virulent pneumococci in deposition and degradation of covalently bound C3b. Implications for phagocytosis and antibody production. J. Infect. Dis. 153:682-693.
22. Lacks, S., and M. Neuberger. 1975. Membrane localization of a deoxyribonuclease implicated in the genetic transformation of Diplococcus pneumoniae. J. Bacteriol. 124:11321-11329.
23. Liou, W., H. J. Geuze, and J. W. Slot. 1996. Improving structural integrity of cryosections for immunogold labeling. Histochem. Cell Biol. 106:41-58.
24. Lock, R. A., J. C. Paton, and D. Hansman. 1988. Comparative efficacy of pneumococcal neuraminidase and pneumolysin as immunogens protective against Streptococcus pneumoniae. Microb. Pathog. 5:461-467.
25. Klein, J. O. 1981. The epidemiology of pneumococcal disease in infants and children. Rev. Infect. Dis. 3:246-253.
26. McDaniel, L. S., G. Scott, J. F. Kearney, and D. E. Briles. 1984. Monoclonal antibodies against protease sensitive pneumococcal antigens protect mice from lethal infections with Streptococcus pneumoniae. J. Exp. Med. 160:386-397.
27. McDaniel, L. S., G. Scott, K. Widenhofer, J. M. Caroll, and D. E. Briles. 1986. Analysis of a surface protein of Streptococcus pneumoniae recognized by protective monoclonal antibodies. Microb. Pathog. 1:519-531.
28. McDaniel, L. S., J. S. Sheffield, F. Delucchi, and D. E. Briles. 1991. PspA, a surface protein of Streptococcus pneumoniae, is capable of eliciting protection against pneumococci of more than one capsular type. Infect. Immun. 59:222-228.
29. Mollnes, T. E., T. Lea, S. S. Froland, and M. Harboe. 1985. Quantification of the terminal complement complex in human plasma by an enzyme-linked immunosorbent assay based on monoclonal antibodies against a neoantigen of the complex. Scand. J. Immunol. 22:197-202.
30. Mollnes, T. E., T. Lea, M. Harboe, and J. Tschopp. 1985. Monoclonal antibodies recognizing a neoantigen of poly (C9) detect the human terminal complement complex in tissue and plasma. Scand. J. Immunol. 22:183-195.
31. Paton, J. C., A. M. Berry, and R. A. Lock. 1997. Molecular analysis of putative pneumococcal virulence proteins. Microb. Drug Resist. 3:1-10.
32. Reed, L. J., and H. Muench. 1938. A simple method of estimating fifty percent endpoints. Am. J. Hyg. 27:493-497.
33. Riley, I. D., and R. M. Douglas. 1981. An epidemiologic approach to pneumococcal disease. Rev. Infect. Dis. 3:233-245.
34. Rosonow, C., P. Ryan, J. N. Weiser, S. Johnson, P. Fontan, A. Ortqvist, and H. R. Masure. 1997. Contribution of novel choline-binding proteins to adherence, colonisation and immunogenicity of Streptococcus pneumoniae. Mol. Microbiol. 25:819-829.
35. Rubins, J. B., and E. N. Janoff. 1998. Pneumolysin: a multifunctional pneumococcal virulence factor. J. Lab. Clin. Med. 131:21-27.
36. Rijkers, G. T. 1986. Anti-pneumococcal polysaccharide ELISA. J. Immunol. Methods 88:185-186.
37. Sanders, A. M., R. G. Feldman, M. M. Voorhorst-Ogink, M. de Haas, G. T. Rijkers, P. J. A. Capel, B. J. M. Zegers, and J. G. J. van de Winkel. 1995. Human immunoglobulin G (IgG) Fc receptor IIA (CD32) polymorphism and IgG2-mediated bacterial phagocytosis by neutrophils. Infect. Immun. 63:73-81.
38. Slot, J. W., H. J. Geuze, S. Gigengack, G. E. Lienhard, and D. E. James. 1991. Immunolocalisation of the insulin regulatable glucose transporter in brown adipose tissue of the rat. J. Cell Biol. 113:123-135.
39. Stephens, C. G., R. C. Williams, and W. P. Reed. 1977. Classical and alternative complement pathway activation by pneumococci. Infect. Immun. 17: 296-302.
40. Tuomanen, E., B. Hengstler, O. Zak, and A. Tomasz. 1986. The role of complement in inflammation during experimental pneumococcal meningitis. Microb. Pathog. 1:15-32.
41. Van Dijk, H., P. M. Rademaker, and J. M. N. Willers. 1980. Estimation of the classical pathway of mouse complement activity by use of sensitized rabbit erythrocytes. J. Immunol. Methods 39:257-268.
42. Vinther Nielsen, S., and J. Henrichsen. 1992. Capsular serotypes of Streptococcus pneumoniae isolated from blood and CSF during 1982-1987. Clin. Infect. Dis. 15:794-798.
43. Watson, D. A., and D. M. Musher. 1990. Interruption of capsule production in Streptococcus pneumoniae serotype 3 by insertion of transposon Tn916. Infect. Immun. 58:3135-3138.
44. Watson, D. A., D. M. Musher, and J. Verhoef. 1995. Pneumococcal virulence factors and host responses to them. Eur. J. Clin. Microbiol. Infect. Dis. 14:479-490.
45. Whaley, K. 1985. Purification of complement components and preparation of antisera, p. 721-764. In K. Whaley (ed.) Methods in complement for clinical immunologists. Churchill-Livingstone, Edinburgh, United Kingdom.
46. Winkelstein, J. A. 1981. The role of complement in the host's defense against Streptococcus pneumoniae. Rev. Infect. Dis. 3:289-298.
47. Yother, J., and J. M. White. 1994. Novel surface attachment mechanisms of the Streptococcus pneumoniae protein PspA. J. Bacteriol. 176:2976-2985.